Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients

Critical Care Medicine

Volumn 26, Issue 4, 1998, Pages 676-684

  Cammarano, William B ^a,b   Pittet, Jean Francois ^a   Weitz, Sandra ^a   Schlobohm, Richard M ^a   Marks, James D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Acute respiratory distress syndrome; Benzodiazepines; Haloperidol; Intensive care unit; Neuromuscular blocking agents; Opiate dependence; Opioid analgesics; Propofol; Substance withdrawal syndrome

Indexed keywords

ANALGESIC AGENT; BENZODIAZEPINE DERIVATIVE; COCODAMOL; DIAZEPAM; FENTANYL; HYDROMORPHONE; HYPNOTIC AGENT; LORAZEPAM; MIDAZOLAM; MORPHINE; NEUROLEPTIC AGENT; NEUROMUSCULAR BLOCKING AGENT; OPIATE DERIVATIVE; OXYCODONE; PROPOFOL; SEDATIVE AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANXIETY NEUROSIS; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; DELIRIUM; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSPHORIA; FEMALE; HUMAN; INSOMNIA; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE CRAMP; MYALGIA; MYOCLONUS; NAUSEA; PRIORITY JOURNAL; RESTLESSNESS; RETROSPECTIVE STUDY; WITHDRAWAL SYNDROME;

ACUTE DISEASE; ADULT; AGED; ANALGESICS, OPIOID; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALOPERIDOL; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PROPOFOL; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 0031919534     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199804000-00015     Document Type: Article

References (31)

1. Wijdicks E, Sharbrough F: New-onset seizures in critically ill patients. Neurology 1993; 43:1042-1043
2. Mets B, Horsell A, Linton D: Midazolam-induced benzodiazepine withdrawal syndrome. Anaesthesia 1991; 46:28-29
3. Hantson P, Clemessy J, Baud F: Withdrawal syndrome following midazolam infusion. Intensive Care Med 1995; 21:190-191
4. Stoelting R, Miller R: Intravenous anesthetics. In: Basics of Anesthesia. Third Edition. Stoelting R, Miller RD (Eds). New York, Churchill Livingstone, 1994, p 67
5. Arnold J, Truog R, Orav E, et al: Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology 1990; 73:1136-1140
6. Reves J, Glass P, Lubarsky D: Nonbarbiturate intravenous anesthetics. In: Anesthesia. Fourth Edition. Miller RD (Ed). New York, Churchill Livingstone, 1994, p 251
7. Sinatra R: Postoperative analgesia, epidural and spinal techniques. In: Obstetric Anesthesia: Principles and Practice. Chestnut D (Ed). St Louis, Mosby, 1994, p 518
8. Bernard G, Artigas A, Brigham K, et al: Report of the American-European consensus conference on acute respiratory distress syndrome: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. J Crit Care 1994; 9:72-81
9. Himmelsbach C: Studies of certain addiction characteristics of (a) dihydromorphone ("paramorphan"), (b) dihydroesoxymorphine-D, ("desmorphine"), (c) dihydrodesoxycodeine-D ("descodeine") and (d) methylhydromophinone ("metophon"). J Pharmacol Exp Ther 1939; 67:239-249
10. O'Brien P: Drug addiction and drug abuse. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics. Hardman J, Limbird L (Eds). New York, McGraw-Hill, 1996, pp 564-568
11. George C, Robertson D: Clinical consequences of abrupt drug withdrawal. Medical Toxicology 1987; 2:367-382
12. Bickel W, Stitzer M, Liebson I, et al: Acute physical dependence in man: Effects of naloxone after brief morphine exposure. J Pharmacol Exp Ther 1988; 244:126-132
13. Shapiro B, Warren J, Egol A, et al: Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Crit Care Med 1995; 23:1596-1600
14. Shafer A, White P, Schuttler J, et al: Use of fentanyl infusion in the intensive care unit: Tolerance to its anesthetic effects? Anesthesiology 1983; 59:245-248
15. Marshall H, Porteous C, MacPherson S: Relief of pain by infusion of morphine after operation: Does tolerance develop? BMJ 1985; 291:19-21
16. Busto U, Sellers E: Pharmacologic aspects of benzodiazepine tolerance and dependence. J Subst Abuse Treat 1991; 8:29-33
17. Windh R, Little P, Kuhn C: The ontogeny of mu opiate tolerance and dependence in the rat: Antinociceptive and biochemical studies. J Pharmacol Exp Ther 1995; 273:1361-1374
18. Buck M, Blumer J: Opioids and other analgesics: Adverse effects in the intensive care unit. Crit Care Clin 1991; 7:615-637
19. Busto U, Sykora K, Sellers E: A clinical scale to assess benzodiazepine withdrawal. J Clin Psychopharmacol 1989; 9:412-416
20. Spies C, Dubisz N, Neumann T, et al: Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: Results of a prospective, randomized trial. Crit Care Med 1996; 24:414-422
21. Au J, Walker W, Scott D: Withdrawal syndrome after propofol infusion. Anaesthesia 1990; 45:741-742
22. Hovav E, Weinstock M: Temporal factors influencing the development of acute tolerance to opiates. J Pharmacol Exp Ther 1987; 242:251-256
23. Sosnowski M, Yaksh T: Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. Anesthesiology 1990; 73:1141-1147
24. Tobias J, Schleien C, Haun S: Methadone as treatment for iatrogenic narcotic dependency in pediatric intensive care unit patients. Crit Care Med 1990; 18:1292-1293
25. Bohrer H, Schmidt H, Bach A, et al: Methadone treatment of opioid withdrawal in intensive care patients. Lancet 1993; 341:636-637
26. Katz R, Kelly W, Hsi A: Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med 1994; 22:763-767
27. Finnegan L: Neonatal abstinence syndrome. In: Neonatal Therapy. Bubatelli F (Ed). New York, Elsevier, 1986, pp 122-146
28. Woolf D: Detoxification. In: Substance Abuse: Pharmacologic, Developmental and Clinical Aspects. Bennett G, Woolf D (Eds). Albany, NY, Delmar, 1991, pp 214-227
29. Hansen-Flaschen J, Brazinsky S, Basile C, et al: Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. JAMA 1991; 266:2870-2875
30. Mark P, Kaufman D: The effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients. Chest 1996; 109:1038-1042
31. Watling S, Dasta J: Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: A review of the literature. Crit Care Med 1994; 22:884-893